News for Next Science Limited (NXSCF)

Published at

Sep 14, 2024 9:20 PM

by gurufocus.com

positive

positive

Full Year 2023 Next Science Ltd Earnings Call Transcript

Feb 27, 2024 / 10:30PM GMTFrancoise Dixon - Next Science Ltd - Head of Investor Relations Good morning, everyone, and welcome to the Next Science Limited FY '23

NXSCF NXS.AX

Read more →
Published at

Apr 24, 2024 12:15 AM

by marketscreener.com

neutral

neutral

Transcript : Next Science Limited, Q1 2024 Earnings Call, Apr 24, 2024

Presenter SpeechFrançoise Dixon Textbox at the bottom of the screen, I'll now hand over to IV for the Q1 update.Presenter SpeechHarry Hall Thanks, Francois. Good morning, everyone, and thank you for...

NXSCF NXS.AX

Read more →
Published at

Apr 30, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

PSQ.AX PGC.AX OSX.AX OPT.AX OPT NOXOF NOX.AX IUGNF IMU.AX GSS.AX CYP.AX CKDXF BPH.AX ATX.AX 4DX.AX ZNO.AX SCU.AX RSH.AX PXSLY PXS.AX PAB.AX OCC.AX NC6.AX KZA.AX KMLXF IHL.AX IDT.AX FDMDF DVL.AX CMP.AX BITRF BIT.AX ARUXF AMT.AX ACR.AX 1AD.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX RNO.AX RHY.AX RHT.AX RGS.AX RAC.AX PYC.AX PNV.AX PCK.AX PBP.AX OVN.AX OSL.AX ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDR.AX MDC.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX ICR.AX HCT.AX GTG.AX GLH.AX EYE.AX DXB.AX CSL.AX CPH.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX AT1.AX ARX.AX AMDHF ALC.AX ADR.AX ADO.AX 1ST.AX

Read more →
Published at

Feb 12, 2023 8:10 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

Will the 'spicy metal' bring the heat in 2023, three stocks with PGE potential, and how to invest in a hedge fund with $5K.

ZEU.AX WEC.AX NVU.AX MME.AX JRL.AX EMD.AX A3D.AX YPB.AX WBE.AX VKA.AX TASEF TAS.AX T3D.AX SVL.AX SRJ.AX SNS.AX SLVMF OZZ.AX NXLLF NXL.AX MMM.AX MKL.AX KEY.AX HCT.AX GPR.AX GGX.AX FRM.AX DOU.AX CSX.AX CAE.AX BTC.AX BAS.AX AQX.AX AD1.AX ZMM.AX WGX.AX SKF.AX RGS.AX RBR.AX QFY.AX NXSCF NXS.AX MGT.AX MCM.AX IPB.AX ICI.AX GTG.AX GLL.AX DRA.AX CYM.AX CLU.AX BYOGF AUQ.AX ASN.AX APXYY APX.AX APPEF

Read more →
Published at

Feb 10, 2023 6:48 AM

by stockhead.com.au

mixed

mixed

Weekly Small Cap and IPO wrap: Large and small caps down this week as Magnetite Mines leads gainers

The ASX has finished the week down with small caps as Magnetite Mines leads the gains impressing investors with two strong announcements.

ZEU.AX SRJ.AX NXLLF NXL.AX NVU.AX MME.AX MHC.AX EMD.AX YPB.AX WBE.AX VKA.AX T3D.AX OZZ.AX MMM.AX MKL.AX KEY.AX HCT.AX GPR.AX GGX.AX FRM.AX DOU.AX CSX.AX BTC.AX BAS.AX AQX.AX AD1.AX ZMM.AX WGX.AX TASEF TAS.AX SVL.AX SNS.AX SLVMF SKF.AX RGS.AX RBR.AX QFY.AX NXSCF NXS.AX MGT.AX MCM.AX IPB.AX ICI.AX GTG.AX GLL.AX DRA.AX CYM.AX CLU.AX BYOGF AUQ.AX ASN.AX APXYY APX.AX APPEF

Read more →
Published at

Feb 7, 2023 8:10 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

Explorers returns to Freo, can Resmed's dream run continue, and AVZ probably isn't listening to Robert Friedland right now.

T3D.AX PLS.AX OLL.AX NXSCF NXS.AX NXL.AX NTL.AX MCT.AX IPB.AX EMU.AX EMD.AX DCG.AX CDX.AX AVR.AX AMD.AX AL3.AX TZN.AX SMX.AX RGS.AX NXLLF MTH.AX LDR.AX CUL.AX WBE.AX VPR.AX NAE.AX KEY.AX DSE.AX AHQDB.AX AHQ.AX

Read more →
Published at

Feb 7, 2023 6:21 AM

by stockhead.com.au

mixed

mixed

CLOSING BELL: RBA delivers Lowe voltage shock with ‘more now, and more to come’ interest rate call

The ASX has stumbled to -0.55% after the RBA hiked interest rates again, while EV Resources made some serious hay, up 46% on a $25m investment commitment.

T3D.AX PLS.AX OLL.AX NXSCF NXS.AX NXLLF NXL.AX NTL.AX MCT.AX EMD.AX DCG.AX CUL.AX AMD.AX AL3.AX TZN.AX SMX.AX RGS.AX OPY.AX NAE.AX MTH.AX LDR.AX IPB.AX EMU.AX CDX.AX AVR.AX WBE.AX VPR.AX KEY.AX DSE.AX ARE.AX AHQDB.AX AHQ.AX

Read more →
Published at

Feb 1, 2023 5:46 PM

by stockhead.com.au

mixed

mixed

Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care

The FDA declined regulate CBD-based supplements and food citing safety reasons, but the CBD index keeps going up.

PYC.AX PSQ.AX PGC.AX MSB.AX KZA.AX EYE.AX DVL.AX CAN.AX BXN.AX BNOEF BNO.AX ADO.AX SOMNF SOM.AX RSH.AX RHT.AX RGS.AX OSX.AX OSL.AX ONE.AX OIL.AX NXSCF NXS.AX MEB.AX MDC.AX MDBIF KMLXF IVX.AX IUGNF IMU.AX IDT.AX GLH.AX CYP.AX CMP.AX CAJ.AX AT1.AX ADR.AX 1ST.AX ZNO.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SCU.AX RNO.AX RHY.AX RAC.AX PXSLY PXS.AX PNV.AX PCK.AX PBP.AX PAB.AX OVN.AX OPT.AX OPT OCC.AX NYR.AX NOXOF NOX.AX NC6.AX MXC.AX MX1.AX MVF.AX MEM.AX MDR.AX LBT.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GTG.AX GSS.AX FDMDF DXB.AX CPH.AX CKDXF CGS.AX CALZF BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ARX.AX ARUXF AMT.AX AMDHF ALC.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Jan 22, 2023 7:10 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

Peregrine reckons it can go better than 122,497g/t, copper juniors ready to produce in 2023, and it's CPI week in Oz.

WFL.AX TNY.AX RLG.AX RBR.AX KWR.AX KSN.AX GLA.AX ADV.AX WBE.AX TSL.AX TKL.AX TASEF TAS.AX SKY.AX PUR.AX PKO.AX PHL.AX NXSCF NXS.AX LER.AX IMD.AX FTC.AX ERL.AX CPT.AX BMO.AX AD1.AX TFL.AX SMX.AX PPY.AX AUR.AX

Read more →
Published at

Jan 20, 2023 6:38 AM

by stockhead.com.au

mixed

mixed

Closing Bell: ASX closes higher and business turnover is booming

The ASX 200 gained 0.23% today and the ASX XEC was up 0.45% with 8 out of 11 sectors higher, led by Energy which rallied by 1.40%.

WHC.AX WFL.AX TNY.AX RLG.AX RBR.AX KWR.AX KSN.AX IMD.AX GLA.AX ADV.AX WBE.AX TSL.AX TKL.AX TASEF TAS.AX SKY.AX PUR.AX PPY.AX PKO.AX PHL.AX NXSCF NXS.AX FTC.AX ERL.AX CPT.AX BMO.AX AUR.AX AD1.AX TFL.AX SMX.AX LER.AX

Read more →
Published at

Jan 19, 2023 5:50 PM

by stockhead.com.au

mixed

mixed

Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device

Japanese startup OUI Inc says it is on a mission to halve the world's blindness with its smartphone-based device.

ZNO.AX ZLD.AX RAP.AX PSQ.AX PIQ.AX PBP.AX PAA.AX MXC.AX IPDQF IPD.AX IDT.AX GLH.AX CGS.AX BXN.AX 1AD.AX SOMNF SOM.AX SHL.AX RSH.AX RGS.AX PGC.AX PCK.AX OVN.AX OSX.AX OSL.AX OIL.AX NYR.AX NXSCF NXS.AX MX1.AX MDC.AX LBT.AX KZIA KZA.AX KMLXF IVX.AX IMMP IMM.AX IHL.AX GSS.AX FDMDF DVL.AX CYP.AX CPH.AX CAN.AX BWXXF BWX.AX BPH.AX BNOEF BNO.AX BITRF BIT.AX AT1.AX ARX.AX AKU.TO AKU ADR.AX 4DX.AX 1ST.AX VTG.AX VLS.AX UBI.AX SCU.AX RNO.AX RHY.AX RHT.AX RAC.AX PYC.AX PXSLY PXS.AX PNV.AX PAB.AX OPT.AX OPT ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MVF.AX MEM.AX MEB.AX MDR.AX MDBIF IUGNF IMU.AX IMRNW IMRN IMC.AX ICR.AX HCT.AX EYE.AX DXB.AX CMP.AX CKDXF CALZF CAJ.AX ATX.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX

Read more →
Published at

Jan 4, 2023 6:02 PM

by stockhead.com.au

mixed

mixed

Check Up: Moderna posts crazy cancer vaccine results, says melanoma recurrence down by almost half

Moderna’s stock price rose in late December after the company revealed that a vaccine for melanoma showed encouraging results.

TD1.AX RSH.AX PCK.AX MX1.AX KMLXF DVL.AX CAJ.AX BNOEF BNO.AX ARX.AX ADR.AX 1ST.AX ZNO.AX RHY.AX RAC.AX PYC.AX PSQ.AX PGC.AX OVN.AX OSX.AX ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MDC.AX KZA.AX IPDQF IPD.AX IDT.AX GTG.AX CYP.AX CPH.AX CAN.AX BXN.AX BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ZLD.AX VTG.AX VLS.AX UBI.AX SOMNF SOM.AX SCU.AX RNO.AX RHT.AX RGS.AX PXSLY PXS.AX PNV.AX PBP.AX PAB.AX OSL.AX OPT.AX OPT OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MVF.AX MEM.AX MDR.AX LBT.AX IVX.AX IUGNF IMU.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GSS.AX GLH.AX FDMDF EYE.AX DXB.AX CMP.AX CKDXF CGS.AX CALZF AT1.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Nov 30, 2022 8:10 PM

by stockhead.com.au

mixed

mixed

Check Up: The world's most expensive drug costs $3.5 MILLION a shot

The US FDA has just approved the world’s most expensive drug. CSL Behring’s hemophilia B gene therapy costs US$3.5m a dose.

PAB.AX OCC.AX NC6.AX MDR.AX IMM.AX GTG.AX GSS.AX EYE.AX CSLN.MX CSLLY CSL.AX CMXHF BPH.AX SHL.AX RAC.AX PSQ.AX ONE.AX NYR.AX NXSCF NXS.AX MXC.AX KZA.AX FDMDF DXB.AX DVL.AX CYP.AX CPH.AX CGS.AX AT1.AX ARX.AX ARUXF AMDHF ALC.AX ACR.AX 4DX.AX ZNO.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX SCU.AX RSH.AX RNO.AX RHY.AX RHT.AX RGS.AX PYC.AX PXSLY PXS.AX PNV.AX PGC.AX PCK.AX PBP.AX OVN.AX OSX.AX OSL.AX OPT.AX OPT OIL.AX NOXOF NOX.AX MX1.AX MVF.AX MEM.AX MEB.AX MDC.AX MDBIF LBT.AX KMLXF IVX.AX IUGNF IPDQF IPD.AX IMU.AX IMRNW IMRN IMC.AX IHL.AX IDT.AX ICR.AX HCT.AX GLH.AX CMP.AX CKDXF CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX BITRF BIT.AX ATX.AX AMT.AX ADR.AX ADO.AX 1ST.AX 1AD.AX

Read more →
Published at

Nov 23, 2022 7:50 PM

by stockhead.com.au

mixed

mixed

How out of favour Biotech has a PR problem and could learn from Dr Karl

ASX health stocks have fallen out of favour in 2022 with a a rotation out of growth into value sectors but could it also do with better PR?

VTG.AX NEU.AX MXC.AX KZA.AX CSL.AX COH.AX BWXXF BWX.AX AT1.AX ADR.AX ADO.AX ZNO.AX ZLD.AX UBI.AX TD1.AX SHL.AX RSH.AX RHT.AX RAC.AX PNV.AX PBP.AX OVN.AX OSX.AX OSL.AX OCC.AX NOXOF NOX.AX MVF.AX MEM.AX MEB.AX MDC.AX MDBIF LBT.AX KMLXF IUGNF IMU.AX ICS.AX ICR.AX EYE.AX CPH.AX CMP.AX CALZF BXN.AX AMDHF 1ST.AX VLS.AX SOMNF SOM.AX SCU.AX RNO.AX RHY.AX RGS.AX PYC.AX PXSLY PXS.AX PSQ.AX PGC.AX PCK.AX PAB.AX OPT.AX OPT ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MX1.AX MDR.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX IDT.AX HCT.AX GTG.AX GSS.AX GLH.AX FDMDF DXB.AX DVL.AX CYP.AX CKDXF CGS.AX CAN.AX CAJ.AX BPH.AX BNOEF BNO.AX BITRF BIT.AX ATX.AX ARX.AX ARUXF AMT.AX ALC.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Nov 2, 2022 8:30 PM

by stockhead.com.au

mixed

mixed

Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations

Four ASX healthcare stocks have been rated as a ‘Strong Buy' by Morningstar’s consensus of brokers, making them hot tips.

ZNO.AX RHT.AX LBT.AX KZA.AX IUGNF IMU.AX ICR.AX EPN.AX ARX.AX ARUXF AMT.AX ALC.AX ACR.AX 1ST.AX ZLD.AX RAC.AX PNV.AX PBP.AX ONE.AX OIL.AX NXSCF NXS.AX MDR.AX IPDQF IPD.AX IMRNW IMRN IMC.AX GTG.AX GSS.AX GLH.AX FDMDF EYE.AX CYP.AX CALZF BNOEF BNO.AX 4DX.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX SCU.AX RSH.AX RNO.AX RHY.AX RGS.AX PYC.AX PXSLY PXS.AX PSQ.AX PGC.AX PCK.AX PAB.AX OVN.AX OSX.AX OSL.AX OPT.AX OPT OCC.AX NYR.AX NOXOF NOX.AX NC6.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDC.AX MDBIF KMLXF IVX.AX IMM.AX IHL.AX IDT.AX HCT.AX DXB.AX DVL.AX CPH.AX CMP.AX CKDXF CGS.AX CAN.AX CAJ.AX BXN.AX BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX AT1.AX AMDHF ADR.AX ADO.AX 1AD.AX

Read more →
Published at

Oct 20, 2022 9:00 PM

by stockhead.com.au

mixed

mixed

Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities?

There were 191 ASX IPOs in calendar year 2021, and 15 of them were biotech stocks.But in 2022 there were only 3 biotech listings.

PXSLY PXS.AX PAB.AX OSL.AX MEM.AX ILA.AX GLH.AX CAJ.AX BPH.AX AMDHF AGN.AX ZLD.AX UBI.AX TD1.AX SCU.AX RSH.AX RNO.AX RHY.AX RGS.AX PYC.AX PGC.AX PBP.AX OSX.AX OPT.AX OPT OIL.AX OCC.AX NXSCF NXS.AX NOXOF NOX.AX NC6.AX MXC.AX MEB.AX MDR.AX MDC.AX MDBIF KMLXF IPDQF IPD.AX IMRNW IMRN IMC.AX IHL.AX HXL.AX GTG.AX EYE.AX DVL.AX CPH.AX CKDXF BWXXF BWX.AX BITRF BIT.AX AT1.AX ARUXF ACR.AX 1ST.AX ZNO.AX VTG.AX VLS.AX SOMNF SOM.AX RHT.AX RAC.AX PSQ.AX PNV.AX PCK.AX OVN.AX ONE.AX NYR.AX MX1.AX MVF.AX LBT.AX KZA.AX IVX.AX IUGNF IMU.AX IMM.AX IDT.AX ICR.AX HCT.AX GSS.AX FDMDF DXB.AX CYP.AX CMP.AX CGS.AX CAN.AX CALZF BXN.AX BNOEF BNO.AX ATX.AX ARX.AX AMT.AX ALC.AX ADR.AX ADO.AX ACW.AX 4DX.AX 1AD.AX

Read more →
Published at

Oct 5, 2022 9:30 PM

by stockhead.com.au

mixed

mixed

Check Up: Blood clots are a $55bn opportunity and these 2 ASX stocks are vying for a slice

Blood clot was top of biotech news this week after researchers revealed new discovery that could prevent it without risk of bleeding.

NOXOF NOX.AX JNJ EX1.AX DJNJ3.BA DJNJ2.BA CGS.AX RCEL PYC.AX PBP.AX OPT.AX OPT OCC.AX NC6.AX MDC.AX KZIA KZA.AX IVX.AX IDT.AX GSS.AX EOFBF EOF.AX DVL.AX CYC.AX CSLN.MX CSLLY CSL.AX CMXHF CKDXF CAN.AX BPH.AX AVH.AX ARX.AX ARUXF AFP.AX ACR.AX 1AD.AX ZLD.AX WFL.AX VTG.AX VLS.AX SPL.AX SCU.AX RNO.AX RGS.AX RAC.AX QURE PXSLY PXS.AX PAB.AX OSL.AX NYR.AX NXSCF NXS.AX MYX.AX MXC.AX MSB.AX MESO MEOBF MEM.AX LGP.AX IUGNF IMU.AX IMRNW IMRN IMMP IMM.AX IMC.AX IHL.AX GTG.AX GENE DXB.AX CYP.AX CPH.AX CGB.AX BNOEF BNO.AX BITRF BIT.AX ATX.AX ADO.AX

Read more →
Published at

Sep 7, 2022 10:10 PM

by stockhead.com.au

mixed

mixed

Check Up: As the pandemic winds down, what’s happening with Covid focused biotechs?

Winter’s nearly over and the Covid surge in Australia has slowed down dramatically. New cases are now rapidly declining.

ZNO.AX RNO.AX RGS.AX PNV.AX LCT.AX IUGNF IMU.AX IMM.AX GSS.AX CALZF BWXXF BWX.AX ANP.AX TD1.AX RSH.AX PXSLY PXS.AX OVN.AX OSX.AX OPT.AX OPT ONE.AX OIL.AX OCC.AX NOXOF NOX.AX KMLXF IPDQF IPD.AX IDT.AX ICR.AX GTG.AX GLH.AX FFC.AX EYE.AX DXB.AX CMP.AX CKDXF CASBF CAN.AX CAJ.AX BXN.AX BNOEF BNO.AX AMDHF ADR.AX 688185.SS 6185.HK ZLD.AX VTG.AX VLS.AX UBI.AX SOMNF SOM.AX SCU.AX RHY.AX RHT.AX RAP.AX RAC.AX PYC.AX PSQ.AX PGC.AX PCK.AX PBP.AX PAB.AX OSL.AX NYR.AX NXSCF NXS.AX NC6.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDR.AX MDC.AX MDBIF LBT.AX KZA.AX IVX.AX IMRNW IMRN IMC.AX IHL.AX HCT.AX FDMDF DVL.AX CYP.AX CPH.AX CGS.AX BITRF BIT.AX ATX.AX AT1.AX ARX.AX ARUXF AMT.AX ALC.AX ADO.AX ACR.AX 4DX.AX 1ST.AX 1AD.AX

Read more →
Published at

Jul 31, 2022 10:30 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

5000 Aussies tell where they're investing next, is green gold real, and top stocks to watch this reporting season.

ZIZTF WBE.AX VMG.AX VIP.AX SZL.AX SEZNL SDV.AX POL.AX OSX.AX OPY.AX NGY.AX NCR.AX MRR.AX MRL.AX MCM.AX INP.AX GNX.AX CVV.AX CBE.AX ANL.AX ZOEFF VMS.AX TMT.AX SMX.AX NWM.AX MMI.AX MEB.AX MDBIF LVTSF LVT.AX KGN.AX KGGNF FGL.AX CPT.AX CFO.AX CFFMF ARN.AX VTMLF VPR.AX TTB.AX TGM.AX TD1.AX T3D.AX SOP.AX RLG.AX RDN.AX PVS.AX PPG.AX NXSCF NXS.AX NVU.AX NUHRF NUH.AX NTO.AX MLS.AX KNO.AX ICG.AX HE8.AX GTN.AX GLV.AX FDMDF DRE.AX DMC.AX CXU.AX CRON CLA.AX CG1.AX CE1.AX AR9.AX AQX.AX 4DX.AX

Read more →
Published at

Jul 29, 2022 9:01 AM

by stockhead.com.au

mixed

mixed

Weekly Small Cap and IPO Wrap: Sezzle up 263% this week; Emerging Co’s up 11% this month; IMF useless all year

It's been a Commonwealth Games silver medal effort from the ASX Emerging Companies (XEC) index - up 4.5% this week, and over 11% for July.

ZIZTF WBE.AX VMG.AX VIP.AX SZL.AX SMX.AX SEZNL SDV.AX POL.AX OSX.AX OPY.AX NGY.AX NCR.AX MRR.AX MRL.AX MCM.AX GNX.AX CBE.AX ANL.AX NWM.AX MMI.AX MEB.AX MDBIF KGN.AX KGGNF FGL.AX CPT.AX CFO.AX CFFMF ARN.AX ZOEFF VPR.AX TTB.AX TGM.AX TD1.AX T3D.AX SOP.AX RLG.AX PVS.AX PPG.AX NXSCF NXS.AX NVU.AX NUHRF NUH.AX NTO.AX LVTSF LVT.AX KNO.AX ICG.AX HE8.AX GTN.AX GLV.AX FDMDF CE1.AX AR9.AX 4DX.AX

Read more →